EZZ LIFE SCIENCE HOLDINGS ORD
EZZ Life Science signs $21m distribution deal for South-East Asia with ROFA Enterprises
EZZ Life Science Holdings (ASX: EZZ) has engaged Australian-owned company ROFA Enterprises to distribute a minimum of $21 million in EZZ-branded products across three key markets in South-East Asia. The three-year non-exclusive agreement commenced this month and allows ROFA to sell the products across Thailand, Vietnam and Singapore. EZZ sees South-East Asia offering significant commercial […]
Market wrap: inflation pushes share prices lower on last trading day of the financial year
Inflation was the word on everybody’s lips as they dumped shares on the last trading day of the financial year but it was the price of goods and services rather than shares that had caught their attention. The week’s stunning news that inflation had reared back up to 4% for the year to May brought […]
EZZ Life Science eyes US market expansion after receiving FDA approval for nine products
EZZ Life Science Holdings (ASX: EZZ) has received approval for nine of its products in the food category from the US Food and Drug Administration (FDA). The EZZ-branded products are Children’s Essential Minerals, Children’s Eye Health, Bone Growth Chews, Brain Focus, Magnesium Plus, Aloe Vera Probiotic Capsules, Liver Detox, Joint Energy Boost Tablets and Men’s […]
EZZ Life Sciences posts strong financial performance for December quarter
Genomic life science company EZZ Life Science (ASX: EZZ) posted a strong financial performance for the three months to December 2022, with $8.6 million in customer cash receipts representing an increase of 43% on the previous quarter and 132% on the same period last year. The company attributed part of the result to the peak […]
